- Home
- SXTP
as 07-26-2024 4:00pm EST
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 3.0M | IPO Year: | 2023 |
| Target Price: | $2.40 | AVG Volume (30 days): | 14.4M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.17 - $2.28 | Next Earning Date: | 08-23-2024 |
| Revenue: | $569,863 | Revenue Growth: | 20.57% |
| Revenue Growth (this year): | 262.03% | Revenue Growth (next year): | 183.33% |
Latest 60 Degrees Pharmaceuticals Inc. News
SXTP Breaking Stock News: Dive into SXTP Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
Clinical Trials Arena
5 days ago
60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial
MT Newswires
7 days ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
7 days ago
Sector Update: Health Care
MT Newswires
7 days ago
Top Midday Gainers
MT Newswires
7 days ago
60 Degrees Signs Testing Deals for Potential Babesiosis Drug -- Shares Rise Pre-Bell
GlobeNewswire
7 days ago
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
GlobeNewswire
18 days ago
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
Compare SXTP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SXTP 60 Degrees Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.